Abacavir Related Compound D

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	AP1443421699
CAS	1443421-69-9
Molecular Weight	428.88

Description	United States Pharmacopeia (USP) Reference Standard
Size	20MG

Fixed-dose Combination Dolutegravir, Abacavir, and Lamivudine Versus Ritonavir-Boosted Atazanavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine in Previously Untreated Women With HIV-1 Infection (ARIA): Week 48 Results From a Randomised, Open-Label, Non-Inferiority, Phase 3b Study

Catherine Orrell, Debbie P Hagins, Elena Belonosova, Norma Porteiro, Sharon Walmsley, Vicenç Falcó, Choy Y Man, Alicia Aylott, Ann M Buchanan, Brian Wynne, Cindy Vavro, Michael Aboud, Kimberly Y Smith, etc.

Lancet HIV. 2017 Dec;4(12):e536-e546.

PMID: 28729158

Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors

Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier, Walter Emil Haefeli

Drug Metab Dispos. 2007 Mar;35(3):340-4.

PMID: 17172311

Once-daily Dolutegravir Versus Darunavir Plus Ritonavir for Treatment-Naive Adults With HIV-1 Infection (FLAMINGO): 96 Week Results From a Randomised, Open-Label, Phase 3b Study

Jean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, Adriano Lazzarin, Matthias Cavassini, Keith Henry, Valeriv Kulagin, Naomi Givens, Carlos Fernando de Oliveira, Clare Brennan, FLAMINGO study team

Lancet HIV. 2015 Apr;2(4):e127-36.

PMID: 26424673

* Products or Services Interested: Abacavir Related Compound D (1443421-69-9)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry